Viewing Study NCT03117933


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-23 @ 8:57 PM
Study NCT ID: NCT03117933
Status: COMPLETED
Last Update Posted: 2024-01-23
First Post: 2017-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
Sponsor: University of Oxford
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRCA1/2 mutation View
None Platinum resistance View